FDA
Oxcarbazepine
The FDA lists this product in 60 strengths and forms.
Composition
- Active ingredients
- OXCARBAZEPINE 300MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- OXCARBAZEPINE 600MG · TabletANDA077802-003 · Prescription
- OXCARBAZEPINE 150MG · TabletANDA077802-001 · Prescription
- OXCARBAZEPINE 300MG · TabletANDA077802-002 · Prescription
- OXCARBAZEPINE 300MG/5ML · SuspensionANDA211420-001 · Discontinued
- OXCARBAZEPINE 300MG/5ML · SuspensionANDA215332-001 · Prescription
- OXCARBAZEPINE 300MG · Tablet, extended releaseANDA217659-002 · Prescription
- OXCARBAZEPINE 600MG · Tablet, extended releaseANDA217659-003 · Prescription
- OXCARBAZEPINE 150MG · Tablet, extended releaseANDA217659-001 · Prescription
- OXCARBAZEPINE 300MG · TabletANDA077747-002 · Prescription
- OXCARBAZEPINE 600MG · TabletANDA077747-003 · Prescription
- OXCARBAZEPINE 150MG · TabletANDA077747-001 · Prescription
- OXCARBAZEPINE 600MG · Tablet, extended releaseANDA205444-003 · Tentative approval
- OXCARBAZEPINE 150MG · Tablet, extended release
At a glance
- Brand name
- Oxcarbazepine
- Route
- Extended release
- Dosage form
- Tablet
- Applicant
- Biocon Pharma LTD
- Status
- Tentative approval
- FDA approval
- 8 Jan 2025
- Application
- ANDA218442-002